ezetimibe has been researched along with Brain Hemorrhage, Cerebral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CC; Chen, HJ; Chen, JS; Liang, CL; Liu, KY; Wang, HK; Wang, KW; Yeh, LR | 1 |
| Elkind, MS; Yaghi, S | 1 |
1 review(s) available for ezetimibe and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Lipids and Cerebrovascular Disease: Research and Practice.
Topics: Brain Ischemia; Cerebral Hemorrhage; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Ezetimibe; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Leukoencephalopathies; Lipoprotein(a); Practice Guidelines as Topic; Primary Prevention; Secondary Prevention; Stroke; Triglycerides | 2015 |
1 other study(ies) available for ezetimibe and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Simvastatin-Ezetimibe enhances growth factor expression and attenuates neuron loss in the hippocampus in a model of intracerebral hemorrhage.
Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Drug Therapy, Combination; Ezetimibe; Hippocampus; Intercellular Signaling Peptides and Proteins; Male; Maze Learning; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Simvastatin | 2021 |